Showing results (831-840 of 883) with videos related to

Sort By:
Pageof 89
Early Intervention in Psychiatry|January 29, 2011
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristicsAnthony P Morrison, Suzanne L K Stewart, Paul French, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2022
Self-sacrificial tyrosine cleavage by an Fe:Mn oxygenase for the biosynthesis of <i>para</i>-aminobenzoate in <i>Chlamydia trachomatis</i>Olivia M Manley, Han N Phan, Allison K Stewart, et al.
Journal of Muscle Research and Cell Motility|October 14, 2000
Human skeletal myosin heavy chain genes are tightly linked in the order embryonic-IIa-IId/x-ILb-perinatal-extraocularJ B Shrager, P R Desjardins, J M Burkman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2014
Crenolanib is a selective type I pan-FLT3 inhibitorCatherine Choy Smith, Elisabeth A Lasater, Kimberly C Lin, et al.
BMC Genomics|March 19, 2013
High-utility conserved avian microsatellite markers enable parentage and population studies across a wide range of speciesDeborah A Dawson, Alexander D Ball, Lewis G Spurgin, et al.
Leukemia|June 12, 2013
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276J Schmidt, E Braggio, K M Kortuem, et al.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
Blood|October 9, 1999
Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantationE C LaCasse, M R Bray, B Patterson, et al.
Structure (London, England : 1993)|May 10, 2000
Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsiteV L Nienaber, D Davidson, R Edalji, et al.
Health Technology Assessment (Winchester, England)|October 17, 2009
A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS studyF M Sullivan, I R C Swan, P T Donnan, et al.
Pageof 89